HEADER IMMUNE SYSTEM 30-JAN-03 1NTL TITLE MODEL OF MOUSE CRRY-IG DETERMINED BY SOLUTION SCATTERING, CURVE TITLE 2 FITTING AND HOMOLOGY MODELLING COMPND MOL_ID: 1; COMPND 2 MOLECULE: COMPLEMENT COMPONENT RECEPTOR 1-LIKE PROTEIN,IG GAMMA-1 COMPND 3 CHAIN C REGION SECRETED FORM; COMPND 4 CHAIN: A, B; COMPND 5 FRAGMENT: Q64735 RESIDUES 83-401,P01868 RESIDUES 98-324; COMPND 6 SYNONYM: COMPLEMENT REGULATORY PROTEIN CRRY,PROTEIN P65; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: CR1L, CRRY, CRY, IGHG1, IGH-4; SOURCE 6 EXPRESSION_SYSTEM: MUS MUSCULUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HOUSE MOUSE; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10090; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: NS/0 PLASMACYTOMA CELLS KEYWDS IMMUNOLOGY, COMPLEMENT, GLYCOPROTEIN, SCR, CCP, IMMUNE SYSTEM EXPDTA SOLUTION SCATTERING NUMMDL 2 MDLTYP CA ATOMS ONLY, CHAIN A, B AUTHOR M.ASLAM,J.M.GUTHRIDGE,B.K.HACK,R.J.QUIGG,V.M.HOLERS,S.J.PERKINS REVDAT 9 14-FEB-24 1NTL 1 REMARK REVDAT 8 13-JUN-18 1NTL 1 REMARK REVDAT 7 25-APR-18 1NTL 1 REMARK REVDAT 6 11-OCT-17 1NTL 1 REMARK REVDAT 5 28-JUN-17 1NTL 1 DBREF REVDAT 4 31-AUG-16 1NTL 1 REMARK VERSN REVDAT 3 07-APR-10 1NTL 1 REMARK REVDAT 2 24-FEB-09 1NTL 1 VERSN REVDAT 1 03-FEB-04 1NTL 0 JRNL AUTH M.ASLAM,J.M.GUTHRIDGE,B.K.HACK,R.J.QUIGG,V.M.HOLERS, JRNL AUTH 2 S.J.PERKINS JRNL TITL THE EXTENDED MULTIDOMAIN SOLUTION STRUCTURES OF THE JRNL TITL 2 COMPLEMENT PROTEIN CRRY AND ITS CHIMAERIC CONJUGATE CRRY-IG JRNL TITL 3 BY SCATTERING, ANALYTICAL ULTRACENTRIFUGATION AND JRNL TITL 4 CONSTRAINED MODELLING: IMPLICATIONS FOR FUNCTION AND THERAPY JRNL REF J.MOL.BIOL. V. 329 525 2003 JRNL REFN ISSN 0022-2836 JRNL PMID 12767833 JRNL DOI 10.1016/S0022-2836(03)00492-3 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : INSIGHT II 98.0 REMARK 3 AUTHORS : MSI REMARK 4 REMARK 4 1NTL COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-FEB-03. REMARK 100 THE DEPOSITION ID IS D_1000018191. REMARK 265 REMARK 265 EXPERIMENTAL DETAILS REMARK 265 REMARK 265 EXPERIMENT TYPE : SMALL ANGLE X-RAY SCATTERING REMARK 265 DATA ACQUISITION REMARK 265 RADIATION/NEUTRON SOURCE : SRS BEAMLINE 2.1 REMARK 265 SYNCHROTRON (Y/N) : Y REMARK 265 BEAMLINE TYPE : 2.1 REMARK 265 BEAMLINE INSTRUMENT : NULL REMARK 265 DETECTOR TYPE : 500-CHANNEL QUADRANT REMARK 265 DETECTOR MANUFACTURER DETAILS : NULL REMARK 265 TEMPERATURE (KELVIN) : 288 REMARK 265 PH : 7.5 REMARK 265 NUMBER OF TIME FRAMES USED : 10 REMARK 265 PROTEIN CONCENTRATION RANGE (MG/ML) : 2-15 REMARK 265 SAMPLE BUFFER : TRIS REMARK 265 DATA REDUCTION SOFTWARE : OTOKO REMARK 265 GUINIER MEAN RADIUS OF GYRATION (NM) : 5.0 REMARK 265 SIGMA MEAN RADIUS OF GYRATION : 0.4 REMARK 265 R(XS-1) MEAN CROSS SECTIONAL RADII (NM) : 1.5 REMARK 265 R(XS-1) SIGMA MEAN CROSS SECTIONAL RADII : 0.1 REMARK 265 R(XS-2) MEAN CROSS SECTIONAL RADII (NM) : NULL REMARK 265 R(XS-2) SIGMA MEAN CROSS SECTIONAL RADII : NULL REMARK 265 P(R) PROTEIN LENGTH (NM) : 1 REMARK 265 REMARK 265 EXPERIMENT TYPE : SMALL ANGLE NEUTRON SCATTERING REMARK 265 DATA ACQUISITION REMARK 265 RADIATION/NEUTRON SOURCE : ILL REMARK 265 SYNCHROTRON (Y/N) : N REMARK 265 BEAMLINE TYPE : NULL REMARK 265 BEAMLINE INSTRUMENT : D11 REMARK 265 DETECTOR TYPE : AREA REMARK 265 DETECTOR MANUFACTURER DETAILS : NULL REMARK 265 TEMPERATURE (KELVIN) : 288 REMARK 265 PH : 7.5 REMARK 265 NUMBER OF TIME FRAMES USED : NULL REMARK 265 PROTEIN CONCENTRATION RANGE (MG/ML) : 8.2 REMARK 265 SAMPLE BUFFER : PBS IN 99.9% D2O REMARK 265 DATA REDUCTION SOFTWARE : DETEC, RNILS, SPOLLY REMARK 265 GUINIER MEAN RADIUS OF GYRATION (NM) : 4.9 REMARK 265 SIGMA MEAN RADIUS OF GYRATION : 0.2 REMARK 265 R(XS-1) MEAN CROSS SECTIONAL RADII (NM) : 1.2 REMARK 265 R(XS-1) SIGMA MEAN CROSS SECTIONAL RADII : 0.2 REMARK 265 R(XS-2) MEAN CROSS SECTIONAL RADII (NM) : NULL REMARK 265 R(XS-2) SIGMA MEAN CROSS SECTIONAL RADII : NULL REMARK 265 P(R) PROTEIN LENGTH (NM) : NULL REMARK 265 REMARK 265 EXPERIMENT TYPE : SMALL ANGLE NEUTRON SCATTERING REMARK 265 DATA ACQUISITION REMARK 265 RADIATION/NEUTRON SOURCE : ISIS REMARK 265 SYNCHROTRON (Y/N) : N REMARK 265 BEAMLINE TYPE : PULSED NEUTRON REMARK 265 BEAMLINE INSTRUMENT : LOQ REMARK 265 DETECTOR TYPE : AREA (TIME-OF-FLIGHT) REMARK 265 DETECTOR MANUFACTURER DETAILS : NULL REMARK 265 TEMPERATURE (KELVIN) : 288 REMARK 265 PH : 7.5 REMARK 265 NUMBER OF TIME FRAMES USED : NULL REMARK 265 PROTEIN CONCENTRATION RANGE (MG/ML) : 4.5-6.8 REMARK 265 SAMPLE BUFFER : PBS IN 99.9% D2O REMARK 265 DATA REDUCTION SOFTWARE : COLLETTE REMARK 265 GUINIER MEAN RADIUS OF GYRATION (NM) : 4.9 REMARK 265 SIGMA MEAN RADIUS OF GYRATION : 0.2 REMARK 265 R(XS-1) MEAN CROSS SECTIONAL RADII (NM) : 1.2 REMARK 265 R(XS-1) SIGMA MEAN CROSS SECTIONAL RADII : 0.2 REMARK 265 R(XS-2) MEAN CROSS SECTIONAL RADII (NM) : NULL REMARK 265 R(XS-2) SIGMA MEAN CROSS SECTIONAL RADII : NULL REMARK 265 P(R) PROTEIN LENGTH (NM) : 1 REMARK 265 REMARK 265 DATA ANALYSIS AND MODEL FITTING: REMARK 265 METHOD USED TO DETERMINE THE STRUCTURE: CONSTRAINED SCATTERING REMARK 265 FITTING OF HOMOLOGY MODELS REMARK 265 SOFTWARE USED : INSIGHT II, HOMOLOGY, DISCOVERY, BIOPOLYMER, REMARK 265 DELPHI, SCTPL5, GNOM REMARK 265 SOFTWARE AUTHORS : MSI REMARK 265 STARTING MODEL : NULL REMARK 265 REMARK 265 CONFORMERS, NUMBER CALCULATED : 2000 REMARK 265 CONFORMERS, NUMBER SUBMITTED : 2 REMARK 265 CONFORMERS, SELECTION CRITERIA : THE MODELLED SCATTERING CURVES REMARK 265 WERE ASSESSED BY CALCULATION OF THE RG, RSX-1 AND VALUES IN THE REMARK 265 SAME Q RANGES USED IN THE EXPERIMENTAL GUINIER FITS. MODELS WERE REMARK 265 THEN RANKED USING A GOODNESS-OF-FIT R-FACTOR DEFINED BY ANALOGY REMARK 265 WITH PROTEIN CRYSTALLOGRAPHY AND BASED ON THE EXPERIMENTAL REMARK 265 CURVES IN THE Q RANGE EXTENDING TO 2.2 NM-1 (X-RAYS) AND 1.12 NM- REMARK 265 1 (ILL NEUTRONS). TWO MODELS ARE SUBMITTED. PLEASE SEE LEGENDS REMARK 265 TO FIGURE 15(B) AND FIGURE 15(C) IN ASLAM ET AL. FOR AN REMARK 265 EXPLANATION OF MODELS 1 AND 2 RESPECTIVELY. REMARK 265 REMARK 265 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 265 REMARK 265 OTHER DETAILS: HOMOLOGY MODELS WERE BUILT FOR THE 5 SCR DOMAINS REMARK 265 AND ENERGY MINIMISATIONS WERE PERFORMED TO IMPROVE THE REMARK 265 CONNECTIVITY IN THE FH MODEL. BIANTENNARY COMPLEX-TYPE REMARK 265 CARBOHYDRATE STRUCTURES (MAN3GLCNAC4GAL2FUC0NEUNAC2) WERE ADDED REMARK 265 TO EACH OF THE N-LINKED GLYCOSYLATION SITES. A LIBRARY OF LINKER REMARK 265 PEPTIDE CONFORMATIONS WAS USED IN DOMAIN MODELLING CONSTRAINED REMARK 265 BY THE SOLUTION SCATTERING FITS. MODELLING WITH THE SCATTERING REMARK 265 DATA WAS ALSO CARRIED OUT BY ROTATIONAL SEARCH METHODS. THE X- REMARK 265 RAY AND NEUTRON SCATTERING CURVE I(Q) WAS CALCULATED ASSUMING A REMARK 265 UNIFORM SCATTERING DENSITY FOR THE SPHERES USING THE DEBYE REMARK 265 EQUATION AS ADAPTED TO SPHERES. X-RAY CURVES WERE CALCULATED REMARK 265 FROM THE HYDRATED SPHERE MODELS WITHOUT CORRECTIONS FOR REMARK 265 WAVELENGTH SPREAD OR BEAM DIVERGENCE, WHILE THESE CORRECTIONS REMARK 265 WERE APPLIED FOR THE NEUTRON CURVES BUT NOW USING UNHYDRATED REMARK 265 MODELS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QUB RELATED DB: PDB REMARK 900 B2 GLYCOPROTEIN I WAS USED AS A TEMPLATE FOR TWO SCR DOMAINS REMARK 900 RELATED ID: 1GKG RELATED DB: PDB REMARK 900 COMPLEMENT RECEPTOR TYPE 1 SCR-17 WAS USED AS A TEMPLATE FOR ONE REMARK 900 SCR DOMAIN REMARK 900 RELATED ID: 1CKL RELATED DB: PDB REMARK 900 MEMBRANE COFACTOR PROTEIN SCR-1 WAS USED AS A TEMPLATE FOR ONE SCR REMARK 900 DOMAIN REMARK 900 RELATED ID: 1VVC RELATED DB: PDB REMARK 900 VACCINIA COAT PROTEIN SCR-4 WAS USED AS A TEMPLATE FOR ONE SCR REMARK 900 DOMAIN REMARK 900 RELATED ID: 1IGY RELATED DB: PDB REMARK 900 THE FC FRAGMENT OF MOUSE IGG1 WAS USED AS A TEMPLATE FOR MODELLING REMARK 999 REMARK 999 SEQUENCE REMARK 999 INSERTED LINKER PEPTIDE (LADPE) REMARK 999 CONFLICTING RESIDUES 1 AND 82 IN BOTH CHAINS REMARK 999 REPRESENT POSSIBLE POLYMORPHISMS DBREF 1NTL A 1 319 UNP Q64735 CR1L_MOUSE 83 401 DBREF 1NTL A 325 551 UNP P01868 IGHG1_MOUSE 98 324 DBREF 1NTL B 1 319 UNP Q64735 CR1L_MOUSE 83 401 DBREF 1NTL B 325 551 UNP P01868 IGHG1_MOUSE 98 324 SEQADV 1NTL ASP A 1 UNP Q64735 GLY 83 CONFLICT SEQADV 1NTL GLU A 82 UNP Q64735 GLN 164 CONFLICT SEQADV 1NTL LEU A 320 UNP Q64735 LINKER SEQADV 1NTL ALA A 321 UNP Q64735 LINKER SEQADV 1NTL ASP A 322 UNP Q64735 LINKER SEQADV 1NTL PRO A 323 UNP Q64735 LINKER SEQADV 1NTL GLU A 324 UNP Q64735 LINKER SEQADV 1NTL LEU A 452 UNP P01868 VAL 225 CONFLICT SEQADV 1NTL ASP B 1 UNP Q64735 GLY 83 CONFLICT SEQADV 1NTL GLU B 82 UNP Q64735 GLN 164 CONFLICT SEQADV 1NTL LEU B 320 UNP Q64735 LINKER SEQADV 1NTL ALA B 321 UNP Q64735 LINKER SEQADV 1NTL ASP B 322 UNP Q64735 LINKER SEQADV 1NTL PRO B 323 UNP Q64735 LINKER SEQADV 1NTL GLU B 324 UNP Q64735 LINKER SEQADV 1NTL LEU B 452 UNP P01868 VAL 225 CONFLICT SEQRES 1 A 551 ASP HIS CYS PRO ALA PRO SER GLN LEU PRO SER ALA LYS SEQRES 2 A 551 PRO ILE ASN LEU THR ASP GLU SER MET PHE PRO ILE GLY SEQRES 3 A 551 THR TYR LEU LEU TYR GLU CYS LEU PRO GLY TYR ILE LYS SEQRES 4 A 551 ARG GLN PHE SER ILE THR CYS LYS GLN ASP SER THR TRP SEQRES 5 A 551 THR SER ALA GLU ASP LYS CYS ILE ARG LYS GLN CYS LYS SEQRES 6 A 551 THR PRO SER ASP PRO GLU ASN GLY LEU VAL HIS VAL HIS SEQRES 7 A 551 THR GLY ILE GLU PHE GLY SER ARG ILE ASN TYR THR CYS SEQRES 8 A 551 ASN GLN GLY TYR ARG LEU ILE GLY SER SER SER ALA VAL SEQRES 9 A 551 CYS VAL ILE THR ASP GLN SER VAL ASP TRP ASP THR GLU SEQRES 10 A 551 ALA PRO ILE CYS GLU TRP ILE PRO CYS GLU ILE PRO PRO SEQRES 11 A 551 GLY ILE PRO ASN GLY ASP PHE PHE SER SER THR ARG GLU SEQRES 12 A 551 ASP PHE HIS TYR GLY MET VAL VAL THR TYR ARG CYS ASN SEQRES 13 A 551 THR ASP ALA ARG GLY LYS ALA LEU PHE ASN LEU VAL GLY SEQRES 14 A 551 GLU PRO SER LEU TYR CYS THR SER ASN ASP GLY GLU ILE SEQRES 15 A 551 GLY VAL TRP SER GLY PRO PRO PRO GLN CYS ILE GLU LEU SEQRES 16 A 551 ASN LYS CYS THR PRO PRO PRO TYR VAL GLU ASN ALA VAL SEQRES 17 A 551 MET LEU SER GLU ASN ARG SER LEU PHE SER LEU ARG ASP SEQRES 18 A 551 ILE VAL GLU PHE ARG CYS HIS PRO GLY PHE ILE MET LYS SEQRES 19 A 551 GLY ALA SER SER VAL HIS CYS GLN SER LEU ASN LYS TRP SEQRES 20 A 551 GLU PRO GLU LEU PRO SER CYS PHE LYS GLY VAL ILE CYS SEQRES 21 A 551 ARG LEU PRO GLN GLU MET SER GLY PHE GLN LYS GLY LEU SEQRES 22 A 551 GLY MET LYS LYS GLU TYR TYR TYR GLY GLU ASN VAL THR SEQRES 23 A 551 LEU GLU CYS GLU ASP GLY TYR THR LEU GLU GLY SER SER SEQRES 24 A 551 GLN SER GLN CYS GLN SER ASP GLY SER TRP ASN PRO LEU SEQRES 25 A 551 LEU ALA LYS CYS VAL SER ARG LEU ALA ASP PRO GLU VAL SEQRES 26 A 551 PRO ARG ASP CYS GLY CYS LYS PRO CYS ILE CYS THR VAL SEQRES 27 A 551 PRO GLU VAL SER SER VAL PHE ILE PHE PRO PRO LYS PRO SEQRES 28 A 551 LYS ASP VAL LEU THR ILE THR LEU THR PRO LYS VAL THR SEQRES 29 A 551 CYS VAL VAL VAL ASP ILE SER LYS ASP ASP PRO GLU VAL SEQRES 30 A 551 GLN PHE SER TRP PHE VAL ASP ASP VAL GLU VAL HIS THR SEQRES 31 A 551 ALA GLN THR GLN PRO ARG GLU GLU GLN PHE ASN SER THR SEQRES 32 A 551 PHE ARG SER VAL SER GLU LEU PRO ILE MET HIS GLN ASP SEQRES 33 A 551 TRP LEU ASN GLY LYS GLU PHE LYS CYS ARG VAL ASN SER SEQRES 34 A 551 ALA ALA PHE PRO ALA PRO ILE GLU LYS THR ILE SER LYS SEQRES 35 A 551 THR LYS GLY ARG PRO LYS ALA PRO GLN LEU TYR THR ILE SEQRES 36 A 551 PRO PRO PRO LYS GLU GLN MET ALA LYS ASP LYS VAL SER SEQRES 37 A 551 LEU THR CYS MET ILE THR ASP PHE PHE PRO GLU ASP ILE SEQRES 38 A 551 THR VAL GLU TRP GLN TRP ASN GLY GLN PRO ALA GLU ASN SEQRES 39 A 551 TYR LYS ASN THR GLN PRO ILE MET ASN THR ASN GLY SER SEQRES 40 A 551 TYR PHE VAL TYR SER LYS LEU ASN VAL GLN LYS SER ASN SEQRES 41 A 551 TRP GLU ALA GLY ASN THR PHE THR CYS SER VAL LEU HIS SEQRES 42 A 551 GLU GLY LEU HIS ASN HIS HIS THR GLU LYS SER LEU SER SEQRES 43 A 551 HIS SER PRO GLY LYS SEQRES 1 B 551 ASP HIS CYS PRO ALA PRO SER GLN LEU PRO SER ALA LYS SEQRES 2 B 551 PRO ILE ASN LEU THR ASP GLU SER MET PHE PRO ILE GLY SEQRES 3 B 551 THR TYR LEU LEU TYR GLU CYS LEU PRO GLY TYR ILE LYS SEQRES 4 B 551 ARG GLN PHE SER ILE THR CYS LYS GLN ASP SER THR TRP SEQRES 5 B 551 THR SER ALA GLU ASP LYS CYS ILE ARG LYS GLN CYS LYS SEQRES 6 B 551 THR PRO SER ASP PRO GLU ASN GLY LEU VAL HIS VAL HIS SEQRES 7 B 551 THR GLY ILE GLU PHE GLY SER ARG ILE ASN TYR THR CYS SEQRES 8 B 551 ASN GLN GLY TYR ARG LEU ILE GLY SER SER SER ALA VAL SEQRES 9 B 551 CYS VAL ILE THR ASP GLN SER VAL ASP TRP ASP THR GLU SEQRES 10 B 551 ALA PRO ILE CYS GLU TRP ILE PRO CYS GLU ILE PRO PRO SEQRES 11 B 551 GLY ILE PRO ASN GLY ASP PHE PHE SER SER THR ARG GLU SEQRES 12 B 551 ASP PHE HIS TYR GLY MET VAL VAL THR TYR ARG CYS ASN SEQRES 13 B 551 THR ASP ALA ARG GLY LYS ALA LEU PHE ASN LEU VAL GLY SEQRES 14 B 551 GLU PRO SER LEU TYR CYS THR SER ASN ASP GLY GLU ILE SEQRES 15 B 551 GLY VAL TRP SER GLY PRO PRO PRO GLN CYS ILE GLU LEU SEQRES 16 B 551 ASN LYS CYS THR PRO PRO PRO TYR VAL GLU ASN ALA VAL SEQRES 17 B 551 MET LEU SER GLU ASN ARG SER LEU PHE SER LEU ARG ASP SEQRES 18 B 551 ILE VAL GLU PHE ARG CYS HIS PRO GLY PHE ILE MET LYS SEQRES 19 B 551 GLY ALA SER SER VAL HIS CYS GLN SER LEU ASN LYS TRP SEQRES 20 B 551 GLU PRO GLU LEU PRO SER CYS PHE LYS GLY VAL ILE CYS SEQRES 21 B 551 ARG LEU PRO GLN GLU MET SER GLY PHE GLN LYS GLY LEU SEQRES 22 B 551 GLY MET LYS LYS GLU TYR TYR TYR GLY GLU ASN VAL THR SEQRES 23 B 551 LEU GLU CYS GLU ASP GLY TYR THR LEU GLU GLY SER SER SEQRES 24 B 551 GLN SER GLN CYS GLN SER ASP GLY SER TRP ASN PRO LEU SEQRES 25 B 551 LEU ALA LYS CYS VAL SER ARG LEU ALA ASP PRO GLU VAL SEQRES 26 B 551 PRO ARG ASP CYS GLY CYS LYS PRO CYS ILE CYS THR VAL SEQRES 27 B 551 PRO GLU VAL SER SER VAL PHE ILE PHE PRO PRO LYS PRO SEQRES 28 B 551 LYS ASP VAL LEU THR ILE THR LEU THR PRO LYS VAL THR SEQRES 29 B 551 CYS VAL VAL VAL ASP ILE SER LYS ASP ASP PRO GLU VAL SEQRES 30 B 551 GLN PHE SER TRP PHE VAL ASP ASP VAL GLU VAL HIS THR SEQRES 31 B 551 ALA GLN THR GLN PRO ARG GLU GLU GLN PHE ASN SER THR SEQRES 32 B 551 PHE ARG SER VAL SER GLU LEU PRO ILE MET HIS GLN ASP SEQRES 33 B 551 TRP LEU ASN GLY LYS GLU PHE LYS CYS ARG VAL ASN SER SEQRES 34 B 551 ALA ALA PHE PRO ALA PRO ILE GLU LYS THR ILE SER LYS SEQRES 35 B 551 THR LYS GLY ARG PRO LYS ALA PRO GLN LEU TYR THR ILE SEQRES 36 B 551 PRO PRO PRO LYS GLU GLN MET ALA LYS ASP LYS VAL SER SEQRES 37 B 551 LEU THR CYS MET ILE THR ASP PHE PHE PRO GLU ASP ILE SEQRES 38 B 551 THR VAL GLU TRP GLN TRP ASN GLY GLN PRO ALA GLU ASN SEQRES 39 B 551 TYR LYS ASN THR GLN PRO ILE MET ASN THR ASN GLY SER SEQRES 40 B 551 TYR PHE VAL TYR SER LYS LEU ASN VAL GLN LYS SER ASN SEQRES 41 B 551 TRP GLU ALA GLY ASN THR PHE THR CYS SER VAL LEU HIS SEQRES 42 B 551 GLU GLY LEU HIS ASN HIS HIS THR GLU LYS SER LEU SER SEQRES 43 B 551 HIS SER PRO GLY LYS CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1